Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Greenwich LifeSciences (GLSI) Interest & Investment Income (2021 - 2025)

Greenwich LifeSciences filings provide 5 years of Interest & Investment Income readings, the most recent being $22797.0 for Q3 2025.

  • Quarterly Interest & Investment Income fell 62.22% to $22797.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $111384.0 through Sep 2025, down 58.49% year-over-year, with the annual reading at $223008.0 for FY2024, 48.86% down from the prior year.
  • Interest & Investment Income hit $22797.0 in Q3 2025 for Greenwich LifeSciences, up from $20675.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $119453.0 in Q2 2023 and bottomed at $3568.0 in Q3 2021.
  • Average Interest & Investment Income over 5 years is $50994.6, with a median of $43942.0 recorded in 2024.
  • The largest annual shift saw Interest & Investment Income skyrocketed 1694.76% in 2022 before it plummeted 62.55% in 2025.
  • Greenwich LifeSciences' Interest & Investment Income stood at $16501.0 in 2021, then skyrocketed by 531.3% to $104171.0 in 2022, then decreased by 14.28% to $89294.0 in 2023, then plummeted by 50.79% to $43942.0 in 2024, then crashed by 48.12% to $22797.0 in 2025.
  • Per Business Quant, the three most recent readings for GLSI's Interest & Investment Income are $22797.0 (Q3 2025), $20675.0 (Q2 2025), and $23970.0 (Q1 2025).